Pharma
AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing
AstraZeneca announces an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance life sciences in China. ...
Arecor establishes partnership with Skye Bioscience to develop enhanced formulation of obesity candidate Nimacimab
Arecor Therapeutics plc, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces a formulation development collaboration with Skye Bioscience, a clinical-stage biotechnology company focused on obesity and other metabolic health disorders. ...
Chinese biopharma out-licensing: Ushering in a new era for UK-China collaboration in 2025
Disclaimer: This article is intended for industry professionals and provides general educational information only. It does not promote specific products or constitute medical advice.Introduction ...
Her Royal Highness The Princess Royal Officially Opens Insmed’s New Research and Development Facility in Cambridge, UK
LONDON, Friday 18 July 2025, Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today welcomes the opening of a new research and developm...
Revenue growth continues - H1 and Q2 2025 results
Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said:“Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent, with 12 positive key Phase III trial readout...
The invisible infrastructure of innovation: Why Data Governance is foundational to the future of healthcare
Co-authored by Sebastian Sbirna, Novo NordiskIn the race to transform healthcare, technology steals the spotlight, AI-driven diagnostics, personalised medicine, and digital therapeutics dominate headlines. But behind the scenes, there is a quieter, less glamorous foundation upon which a...
Transforming patient care and provider efficiency
Co-authored Cassie McGrath, Morning Brew
Medicilon receives international accreditation again - successfully obtains OECD GLP Certification Certificate
Recently, Medicilon officially obtained the Good Laboratory Practice (GLP) certification certificate issued by Mexico, a member country of the OECD. In addition, we successfully passed GLP on-site inspections conducted by Hungary. ...
Meet Medicilon at the 23rd SCI-RSC Medicinal Chemistry Symposium
We are excited to announce that Medicilon will be attending the 23rd SCI-RSC Medicinal Chemistry Symposium, taking place on September 14-17, 2025, in Cambridge, England. Meet with Ms. Nadine Su from our team to explore our flexible collaboration models (FFS & FTE) and ou...
Abselion Launches AAVX and AAV9 Total Capsid Quantification Kits
Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistencyCambridge, UK, 09 September 2025: Abselion, a ...